Department of Health Promotion and Health Education,National Taiwan Normal University,Taipei,Taiwan.
Department of Psychiatry,Tri-Service General Hospital,Taipei,Taiwan.
Epidemiol Psychiatr Sci. 2018 Apr;27(2):176-185. doi: 10.1017/S2045796016000950. Epub 2016 Dec 15.
Poor insight is prevalent in patients with schizophrenia and has been associated with acute illness severity, medication non-adherence and poor treatment outcomes. Paradoxically, high insight has been associated with various undesirable outcomes, including low self-esteem, depression and low subjective quality of life (QoL) in patients with schizophrenia. Despite the growing body of studies conducted in Western countries supporting the pernicious effects of improved insight in psychosis, which bases on the level of self-stigma, the effects are unclear in non-Western societies. The current study examined the role of self-stigma in the relationship between insight and psychosocial outcomes in a Chinese population.
A total of 170 outpatients with schizophrenia spectrum disorders were recruited from two general university hospitals. Sociodemographic data and clinical variables were recorded and self-report scales were employed to measure self-stigma, depression, insight, self-esteem and subjective QoL. Structural equation modelling (SEM) was used to analyse the cross-sectional data.
High levels of self-stigma were reported by 39% of the participants (n = 67). The influences of insight, self-stigma, self-esteem and depression on subjective QoL were confirmed by the SEM results. Our model with the closest fit to the data (χ 2 = 33.28; df = 20; p = 0.03; χ 2/df = 1.66; CFI = 0.98; TLI = 0.97; RMSEA = 0.06) demonstrated that self-stigma might fully mediate the association of insight with low self-esteem, depression and poor subjective QoL. High insight into illness contributed to self-stigma, which caused low self-esteem and depression and, consequently, low QoL. Notably, insight did not directly affect self-esteem, depression or QoL. Furthermore, the association of insight with poor psychosocial outcomes was not moderated by self-stigma.
Our findings support the mediating model of insight relevant to the poor psychosocial outcomes of individuals diagnosed with schizophrenia in non-Western societies, in which self-stigma plays a pivotal role. These findings elucidate the direct and indirect effects of insight on psychosocial outcomes and imply that identifying and correcting self-stigma in people with schizophrenia could be beneficial. Additional studies are required to identify whether several other neurocognitive or psychosocial variables mediate or moderate the association of insight with self-esteem, depression and QoL in patients with schizophrenia. Studies with detailed longitudinal assessments are necessary to confirm our findings.
精神分裂症患者的病识感较差,与急性期疾病严重程度、药物依从性差和治疗效果不佳有关。矛盾的是,较高的病识感与各种不良结果相关,包括精神分裂症患者的低自尊、抑郁和低主观生活质量(QoL)。尽管越来越多的西方研究支持改善精神病患者的病识感的有害影响,这种影响是基于自我污名化的程度,但在非西方社会中,这种影响尚不清楚。本研究在中国人群中考察了自我污名化在病识感与心理社会结果之间关系中的作用。
从两所综合大学附属医院共招募了 170 名精神分裂症谱系障碍患者。记录人口统计学数据和临床变量,并采用自报量表评估自我污名、抑郁、病识感、自尊和主观 QoL。采用结构方程模型(SEM)分析横断面数据。
39%(n=67)的参与者报告存在较高水平的自我污名。SEM 结果证实了病识感、自我污名、自尊和抑郁对主观 QoL 的影响。我们最符合数据的模型(χ2=33.28;df=20;p=0.03;χ2/df=1.66;CFI=0.98;TLI=0.97;RMSEA=0.06)表明,自我污名可能完全中介病识感与低自尊、抑郁和较差的主观 QoL 之间的关系。对疾病的高病识感导致自我污名,进而导致低自尊、抑郁和较差的 QoL。值得注意的是,病识感不会直接影响自尊、抑郁或 QoL。此外,自我污名并不调节病识感与较差的心理社会结果之间的关系。
我们的研究结果支持了非西方社会中精神分裂症个体病识感与较差的心理社会结果相关的中介模型,自我污名在其中发挥关键作用。这些发现阐明了病识感对心理社会结果的直接和间接影响,并暗示识别和纠正精神分裂症患者的自我污名可能有益。需要进一步的研究来确定是否有其他神经认知或心理社会变量在精神分裂症患者的病识感与自尊、抑郁和 QoL 之间起中介或调节作用。需要有详细的纵向评估的研究来证实我们的发现。